Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Contrast-enhanced MRI Examination of Cerebral Neoplastic Enhancing Lesions: Comparison of Diagnostic Efficacy of Gd-DOTA 0.5M and Gadobutrol 1.0 M at 0.1 mmol/kg Body Weight: Intraindividual Comparison Clinical Study.

Study to compare of two contrast agents in imaging brain lesions.

Inclusion Criteria:

• Known neoplastic CNS lesions